Average Co-Inventor Count = 4.90
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ludwig Institute for Cancer Research Limited (6 from 525 patents)
2. Licentia, Ltd. (2 from 20 patents)
3. Helsinki University Licensing Ltd. Oy (2 from 5 patents)
4. Other (1 from 832,880 patents)
5. Orion Corporation (1 from 179 patents)
6. Vegenics Pty Limited (1 from 22 patents)
7. Helsinki University Licensing, Ltd. (1 from 15 patents)
9 patents:
1. 8025886 - Modified VEGF-A with improved angiogenic properties
2. 7341996 - Processed vascular endothelial growth factor-B polypeptides
3. 7034105 - FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
4. 6331301 - Antibodies specific for vascular endothelial growth factor-B
5. 6107046 - Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
6. 5928939 - Vascular endothelial growth factor-b and dna coding therefor
7. 5840693 - Vascular endothelial growth factor-B
8. 5776755 - FLT4, a receptor tyrosine kinase
9. 5607918 - Vascular endothelial growth factor-B and DNA coding therefor